QGEN
QIAGEN NV
NYSE · Healthcare · Medical - Diagnostics & Research · NL
$43.33
−2.37%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $0.62
- Revenue estimate
- $536.0M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.62
- EPS estimate
- $0.60
- Revenue actual
- $535.0M
- Revenue estimate
- $527.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -1.7%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $45
- PT range
- $40 – $50
- Analysts
- 5
2 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.60 | $0.62 | Beat 3.68% | $535.0M |
| May 6, 2026 | $0.55 | $0.54 | Miss -1.82% | $492.3M |
| Mar 19, 2026 | $0.60 | $0.52 | Miss -13.62% | $540.4M |
| Nov 4, 2025 | $0.61 | $0.64 | Beat 4.92% | $532.6M |
| May 7, 2025 | $0.50 | $0.55 | Beat 9.34% | $483.5M |
| Feb 5, 2025 | $0.60 | $0.61 | Beat 1.67% | $521.2M |
| Jul 31, 2024 | $0.53 | $0.57 | Beat 7.55% | $496.3M |
| May 3, 2023 | $0.50 | $0.54 | Beat 8.00% | $485.4M |
| Feb 7, 2023 | $0.50 | $0.56 | Beat 12.00% | $498.0M |
| Jul 26, 2022 | $0.46 | $0.51 | Beat 10.87% | $515.5M |
| Feb 8, 2022 | $0.60 | $0.74 | Beat 23.33% | $582.4M |
| Nov 3, 2021 | $0.53 | $0.58 | Beat 9.43% | $534.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026